Metabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training

被引:575
作者
Roberts, Christian K. [1 ]
Hevener, Andrea L. [2 ]
Barnard, R. James [3 ]
机构
[1] Univ Calif Los Angeles, Sch Nursing, Translat Sci Sect, Exercise & Metab Dis Res Lab, Los Angeles, CA 90024 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Endocrinol, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA
关键词
C-REACTIVE PROTEIN; HUMAN SKELETAL-MUSCLE; NECROSIS-FACTOR-ALPHA; TIME PHYSICAL-ACTIVITY; ENDOPLASMIC-RETICULUM STRESS; SUBCUTANEOUS ADIPOSE-TISSUE; TYPE-2; DIABETES-MELLITUS; TYROSINE-PHOSPHATASE; 1B; ACID-BINDING PROTEIN; ACYLATION-STIMULATING PROTEIN;
D O I
10.1002/cphy.c110062
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Metabolic syndrome (MS) is a collection of cardiometabolic risk factors that includes obesity, insulin resistance, hypertension, and dyslipidemia. Although there has been significant debate regarding the criteria and concept of the syndrome, this clustering of risk factors is unequivocally linked to an increased risk of developing type 2 diabetes and cardiovascular disease. Regardless of the true definition, based on current population estimates, nearly 100 million have MS. It is often characterized by insulin resistance, which some have suggested is a major underpinning link between physical inactivity and MS. The purpose of this review is to: (i) provide an overview of the history, causes and clinical aspects of MS, (ii) review the molecular mechanisms of insulin action and the causes of insulin resistance, and (iii) discuss the epidemiological and intervention data on the effects of exercise on MS and insulin sensitivity. (C) 2013 American Physiological Society. Compr Physiol 3:1-58, 2013.
引用
收藏
页码:1 / 58
页数:58
相关论文
共 733 条
[1]   What is the best predictor of future type 2 diabetes? [J].
Abdul-Ghani, Muhammad A. ;
Williams, Ken ;
DeFronzo, Ralph A. ;
Stern, Michael .
DIABETES CARE, 2007, 30 (06) :1544-1548
[2]   Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test [J].
Abdul-Ghani, Muhammad A. ;
Matsuda, Masafumi ;
Balas, Bogdan ;
DeFronzo, Ralph A. .
DIABETES CARE, 2007, 30 (01) :89-94
[3]   Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver [J].
Abel, ED ;
Peroni, O ;
Kim, JK ;
Kim, YB ;
Boss, O ;
Hadro, E ;
Minnemann, T ;
Shulman, GI ;
Kahn, BB .
NATURE, 2001, 409 (6821) :729-733
[4]  
ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665
[5]  
ABUMRAD NA, 1981, J BIOL CHEM, V256, P9183
[6]   Ceramide content is increased in skeletal muscle from obese insulin-resistant humans [J].
Adams, JM ;
Pratipanawatr, T ;
Berria, R ;
Wang, E ;
DeFronzo, RA ;
Sullards, MC ;
Mandarino, LJ .
DIABETES, 2004, 53 (01) :25-31
[7]   INSULIN SENSITIVITY IN THE INTACT ORGANISM [J].
ADER, M ;
BERGMAN, RN .
BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1987, 1 (04) :879-910
[8]   Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action [J].
Aguirre, V ;
Werner, ED ;
Giraud, J ;
Lee, YH ;
Shoelson, SE ;
White, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (02) :1531-1537
[9]   The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307 [J].
Aguirre, V ;
Uchida, T ;
Yenush, L ;
Davis, R ;
White, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) :9047-9054
[10]   Distinct physiologic and neuronal responses to decreased leptin and mild hyperleptinemia [J].
Ahima, RS ;
Kelly, J ;
Elmquist, JK ;
Flier, JS .
ENDOCRINOLOGY, 1999, 140 (11) :4923-4931